< 1 minute read
Sep. 15, 2021
Compound 25: A RORγt oral in vivo allosteric inhibitor
"compound 25"-2
RORγt allosteric inhibitor Orally bioavailable in higher species from HTS and ligand-based design ACS Med. Chem. Lett. 11, 114-119 Merck, Boston, MA
Loading...
